The goal of this prospective observational study is to generate new personalised 3D preclinical models of pancreatic neuroendocrine tumors. The models will be exploited for studying the mechanisms underlying disease development and progression, as well as for performing drug testing. For the development of the newly proposed models, patients' surgical specimens will be evaluated by the Pathological Unit. If the presence of pathological material in excess, not required for the routine diagnostic procedure, is confirmed, such material will be employed for the generation of the proposed personalised models.
patients who undergo pancreatic surgical resection for non-functioning pancreatic neuroendocrine tumor
age ≥ 18 years
informed consent
non-pancreatic neuroendocrine tumor histological diagnosis
age < 18 years
A total number of approximately 70 patients will be enrolled
Other
Prospective
Not listed
Development of New Personalised 3D Preclinical Models of Pancreatic Neuroendocrine Tumours
Generation of new 3D preclinical models of pancreatic neuroendocrine tumors for the study of the disease biology and for the assessment of drug response
Click on the lead sponsor to view all of their trials.
